Back to Search
Start Over
Dopaminergic transmission in STOP null mice
- Source :
- Journal of Neurochemistry, Journal of Neurochemistry, 2005, 94 (1), pp.63-73. ⟨10.1111/j.1471-4159.2005.03166.x⟩, Journal of Neurochemistry, Wiley, 2005, 94 (1), pp.63-73. ⟨10.1111/j.1471-4159.2005.03166.x⟩
- Publication Year :
- 2005
- Publisher :
- HAL CCSD, 2005.
-
Abstract
- International audience; Neuroleptics are thought to exert their anti-psychotic effects by counteracting a hyper-dopaminergic transmission. Here, we have examined the dopaminergic status of STOP (stable tubule only polypeptide) null mice, which lack a microtubule-stabilizing protein and which display neuroleptic-sensitive behavioural disorders. Dopamine transmission was investigated using both behavioural analysis and measurements of dopamine efflux in different conditions. Compared to wild-type mice in basal conditions or following mild stress, STOP null mice showed a hyper-locomotor activity, which was erased by neuroleptic treatment, and an increased locomotor reactivity to amphetamine. Such a behavioural profile is indicative of an increased dopaminergic transmission. In STOP null mice, the basal dopamine concentrations, measured by quantitative microdialysis, were normal in both the nucleus accumbens and the striatum. When measured by electrochemical techniques, the dopamine efflux evoked by electrical stimulations mimicking physiological stimuli was dramatically increased in the nucleus accumbens of STOP null mice, apparently due to an increased dopamine release, whereas dopaminergic uptake and auto-inhibition mechanisms were normal. In contrast, dopamine effluxes were slightly diminished in the striatum. Together with previous results, the present study indicates the association in STOP null mice of hippocampal hypo-glutamatergy and of limbic hyper-dopaminergy. Such neurotransmission defects are thought to be central to mental diseases such as schizophrenia.
- Subjects :
- Male
Light
Action Potentials
Striatum
Biochemistry
Synaptic Transmission
MESH: Mice, Knockout
chemistry.chemical_compound
Mice
0302 clinical medicine
Basal ganglia
MESH: Animals
MESH: Nerve Tissue Proteins
Neurotransmitter
MESH: Action Potentials
Mice, Knockout
0303 health sciences
Dopaminergic
limbic
MESH: Darkness
MESH: Electric Stimulation
cytoskeleton
neuroleptics
Darkness
MESH: Motor Activity
Circadian Rhythm
[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
dopamine
Microtubule-Associated Proteins
medicine.drug
Antipsychotic Agents
medicine.medical_specialty
Nerve Tissue Proteins
MESH: Dopamine
Biology
Nucleus accumbens
Motor Activity
microtubules
03 medical and health sciences
Cellular and Molecular Neuroscience
Dopamine
Internal medicine
medicine
MESH: Synaptic Transmission
Animals
MESH: Circadian Rhythm
[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]
Amphetamine
MESH: Mice
030304 developmental biology
Electric Stimulation
MESH: Light
MESH: Male
schizophrenia
MESH: Microtubule-Associated Proteins
Endocrinology
chemistry
Catecholamine
MESH: Antipsychotic Agents
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- ISSN :
- 00223042 and 14714159
- Database :
- OpenAIRE
- Journal :
- Journal of Neurochemistry, Journal of Neurochemistry, 2005, 94 (1), pp.63-73. ⟨10.1111/j.1471-4159.2005.03166.x⟩, Journal of Neurochemistry, Wiley, 2005, 94 (1), pp.63-73. ⟨10.1111/j.1471-4159.2005.03166.x⟩
- Accession number :
- edsair.doi.dedup.....e987b2cff7c12dc36dc69a3183483ecf
- Full Text :
- https://doi.org/10.1111/j.1471-4159.2005.03166.x⟩